Sign in
GLPG Stock Price, Chart, Stats & News
Galapagos N.V.
Save
Galapagos N.V. (GLPG) does not currently pay a dividend.
1.84B
Market cap
3.21x
Current P/E
303.03x
Forward P/E
GLPG chart
1M
3M
1Y
5Y
Loading chart...
Fundamentals
Gross margin | 56.02% |
Operating margin | 40.56% |
Pretax margin | 25.98% |
Net margin | 28.85% |
Effective tax rate | -6.19% |
ROA | 9.42% |
ROE | 11.16% |
D/E | 0.00x |
Interest coverage ratio | 17.96x |
GLPG valuation
P/E | 3.21x |
P/S | 1.49x |
P/B | 0.51x |
P/CF | -6.56x |
P/FCF | -6.22x |
P/OCF | -6.56x |
PEG | 0.03x |
EV multiple | 5.92x |
About
Galapagos NV is a biotechnology company, which engages in the identification and development of small molecule and antibody therapies. Its clinical pipeline includes filgotinib, GLP3667, Toledo program, and idiopathic pulmonary fibrosis. The company was founded by Onno van de Stolpe, Rudi Pauwels, and Helmuth van Es on June 30, 1999 and is headquartered in Mechelen, Belgium.
Similar securities
Based on sector and market capitalization
Report issue